Insys To Pay $4.45M To Illinois, Agrees To Restrict Opioid Marketing
CHICAGO — Insys Therapeutics Inc. on Aug. 17 agreed to pay $4.45 million to Illinois and agreed to restrictions on how it markets its opioid drugs in the state, according to...To view the full article, register now.
Already a subscriber? Click here to view full article